SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 43 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,492,975 | $8,536,653,000 | 2.90% |
| Glassman Wealth Services | 72,366 | $137,000 | 0.06% |
| B. Riley Wealth Management, Inc. | 53,500 | $102,000 | 0.02% |
| Sigma Planning Corp | 223,400 | $424,000 | 0.02% |
| Fore Capital, LLC | 40,000 | $76,000 | 0.02% |
| Psagot Value Holdings Ltd. | 218,555 | $415,000 | 0.02% |
| HBK Sorce Advisory LLC | 85,500 | $162,000 | 0.02% |
| WealthTrust Axiom LLC | 10,000 | $19,000 | 0.01% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 12,894 | $24,000 | 0.01% |
| Weiss Asset Management LP | 29,691 | $56,000 | 0.00% |